Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong · Delayed Price · Currency is HKD 1.325
+0.065 (5.16%)
Nov 3, 2026, 4:08 PM HKT
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of 654.3 million as of November 2, 2026. It is the 26,311th most valuable company in the world and the 1,292nd biggest in Hong Kong. Its market cap has decreased by 24.84% in one year.
Market Cap
654.30M
Enterprise Value
772.38M
Revenue
90.90M
Global Rank
Country Rank
#1,292 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 7.94B to 654.30M, a decrease of -91.76%. That is a compound annual growth rate of -32.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 654.30M | -32.36% |
| Dec 31, 2025 | 967.31M | 130.32% |
| Dec 31, 2024 | 419.98M | -42.42% |
| Dec 29, 2023 | 729.42M | -83.45% |
| Dec 30, 2022 | 4.41B | -7.54% |
| Dec 31, 2021 | 4.77B | 23.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhaoke Ophthalmology | 1.10B |
| Cloudbreak Pharma | 1.10B |
| CANbridge Pharmaceuticals | 1.06B |
| Sunho Biologics | 970.43M |
| JW (Cayman) Therapeutics Co. | 901.09M |
| Wuhan YZY Biopharma | 775.40M |
| Brii Biosciences | 707.42M |
| 3D Medicines | 641.85M |